◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

FUJIFILM Holdings Corporation (4901)

Name: FUJIFILM Holdings Corporation（4901）— 財務諸表の推移
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

公式財務諸表に基づく売上高、利益、キャッシュフローの推移。

Industrials · ウォール街（米国） · 最終更新: 2026-10-02

FUJIFILM Holdings Corporation provides products and services in the fields of healthcare, electronics, business innovation, and imaging in Japan, the Americas, Europe, Asia, and internationally. Its Healthcare segment offers products and services, such as medical devices, biomedical contract development and manufacturing organization, pharmaceutical, regenerative medicine, and cosmetics and supplements in the areas of prevention, diagnosis, and treatment; equipment and materials for medical systems; drug discovery support, such as iPS cells; and cell culture media and reagents.

主要指標

時価総額: JPY 3.96 trillion
売上高（2026-03-31 期末の会計年度）: JPY 3.36T
当期純利益: JPY 276.7B
売上総利益率: 40.8%
純利益率: 8.2%

インタラクティブチャートと全財務諸表を見る → バリュエーションモデル（DCF）→

年次損益計算書

損益計算書	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
売上高合計	JPY 3.36T	JPY 3.20T	JPY 2.96T	JPY 2.86T	—
売上総利益	JPY 1.37T	JPY 1.30T	JPY 1.19T	JPY 1.14T	—
営業利益（EBIT）	JPY 350.2B	JPY 330.2B	JPY 276.7B	JPY 273.1B	—
当期純利益	JPY 276.7B	JPY 261.0B	JPY 243.5B	JPY 219.4B	—

出典: 企業の公開資料（SEC）。数値をご利用の前に SEC EDGAR でご確認ください。

貸借対照表、キャッシュフロー計算書、四半期データおよび全財務比率は 4901 のインタラクティブ・ビューアーでご覧いただけます。 /companies/us/4901

類似企業

本サイトの情報は教育および情報提供のみを目的としており、投資助言ではありません。目標株価や投資判断は掲載していません。

English version →全銘柄

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.